UK registered businesses can apply for a share of up to £14.3 million to accelerate the adoption of quantum enabled position, navigation, and timing (PNT) and sensing technologies by addressing specific technical and commercial barriers.
Amount not publishedCloses in 24 days (16 September 2026)UK-wide
Innovate UK, on behalf of the Office for Life Sciences’ (OLS) Cancer Healthcare Goals programme, will invest up to £25.4 million, to support the clinical validation and evaluation of early cancer diagnostic technologies and devices.